Literature DB >> 25226882

A 3-year follow-up of the Silent Diabetes Study.

Oliver Schnell1, Rolf Doerr, Volker Lodwig, Joerg Weissmann, Tobias Lohmann.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25226882     DOI： 10.1007/s00125-014-3378-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.

Authors:  T S Temelkova-Kurktschiev; C Koehler; E Henkel; W Leonhardt; K Fuecker; M Hanefeld
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

2.  C-reactive protein in diabetic and nondiabetic patients with acute myocardial infarction.

Authors:  Wolfgang Otter; Michael Winter; Wittich Doering; Eberhard Standl; Oliver Schnell
Journal:  Diabetes Care       Date:  2007-09-11       Impact factor: 19.112

3.  NT-ProBNP independently predicts long-term mortality in patients admitted for coronary angiography.

Authors:  Martin Huth Ruwald; Jens Peter Goetze; Jan Bech; Olav Wendelboe Nielsen; Bente Kühn Madsen; Lars Bo Nielsen; Mette Mouridsen; Anne-Christine Huth Ruwald; Jan Kyst Madsen; Sune Pedersen
Journal:  Angiology       Date:  2012-10-15       Impact factor: 3.619

4.  Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.

Authors:  R Doerr; U Hoffmann; W Otter; L Heinemann; W Hunger-Battefeld; B Kulzer; A Klinge; V Lodwig; I Amann-Zalan; D Sturm; D Tschoepe; S G Spitzer; J Stumpf; T Lohmann; O Schnell
Journal:  Diabetologia       Date:  2011-07-20       Impact factor: 10.122

5.  Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.

Authors:  Yoichiro Hirakawa; Hisatomi Arima; Sophia Zoungas; Toshiharu Ninomiya; Mark Cooper; Pavel Hamet; Giuseppe Mancia; Neil Poulter; Stephen Harrap; Mark Woodward; John Chalmers
Journal:  Diabetes Care       Date:  2014-05-08       Impact factor: 19.112
  5 in total
  2 in total

1.  The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.

Authors:  Bahira Shahim; Dirk De Bacquer; Guy De Backer; Viveca Gyberg; Kornelia Kotseva; Linda Mellbin; Oliver Schnell; Jaakko Tuomilehto; David Wood; Lars Rydén
Journal:  Diabetes Care       Date:  2017-06-21       Impact factor: 19.112

2.  Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.

Authors:  Eline H Ploumen; Rosaly A Buiten; Marlies M Kok; Carine J M Doggen; K Gert van Houwelingen; Martin G Stoel; Frits H A F de Man; Marc Hartmann; Paolo Zocca; Gerard C M Linssen; Cees Doelman; Gert D Kant; Clemens von Birgelen
Journal:  Catheter Cardiovasc Interv       Date:  2019-10-17       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.